Monthly Archives: February 2020

SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Pure Acquisition Corp. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pure Acquisition Corp. ("Pure" or "the Company") (NASDAQ:PACQ).

The investigation focuses on whether Pure issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576706

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PlayAGS, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PlayAGS, Inc. ("PlayAGS" or "the Company") (NYSE:AGS).

The investigation focuses on whether PlayAGS issued false and/or misleading statements and/or failed to disclose information pertinent to investors pursuant to the Company's March 2019 offering.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576705

IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against NexTech AR Solutions Corp. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NexTech AR Solutions Corp. ("NexTech" or "the Company") (OTCQB:NEXCF) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. NexTech is the subject of a Hindenburg Research report published on February 10, 2020, titled "NexTech AR: Relentless Stock Promotion, Sketchy Related Party Transactions, and a Vaporware Product-Price Target: $0," that alleges the Company has "virtually no credible business prospects and appears to be focused almost entirely on promoting its stock and insider self-dealing." Based on this report, shares of NexTech fell by almost 22% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576702

IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Celanese Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELS, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Celanese reported its full-year and fourth quarter 2019 financial results on January 30, 2020. The Company reported GAAP diluted earnings per share ("EPS") of $0.35 and adjusted EPS of $1.99. Chief Financial Officer Scott Richardson commented on the wide discrepancy by claiming it was related to an $89 million reserve booked by the Company based on a European Commission competition investigation into the Company's subsidiaries. Based on this news, shares of Celanese fell by more than 6% the next day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576704

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Telenav, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELS, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telenav, Inc. ("Telenav" or "the Company") (NASDAQ:TNAV) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Telenav admitted on February 11, 2020, that it would be unable to file its quarterly report for the period ended December 31, 2019, in a timely manner. The Company filed a Form 12b-25 filed with the SEC, stating that it had "updated its reporting of revenue related to its agreements with Grab Holdings, Inc." which resulted in revenue corrections for the quarter ending September 30, 2019, among other adjustments. Telenav also admitted "a material weakness in its internal control over financial reporting as of September 30, 2019 and December 31, 2019."

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576698

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bed Bath & Beyond Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bed Bath & Beyond Inc. ("Bed Bath & Beyond" or "the Company") (NASDAQ:BBBY) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Bed Bath & Beyond issues a press release on February 11, 2020, announcing the Company's fourth quarter 2019 financial results. The Company disclosed "a 5.4% decline in comparable sales driven primarily by store traffic declines combined with inventory management issues." Based on this news, shares of Bed Bath & Beyond traded down by almost 24% in intraday trading on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576701

INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against LogicBio Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. ("LogicBio" or "the Company") (NASDAQ:LOGC) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. LogicBio issued a press release on February 10, 2020, stating "the U.S. Food and Drug Administration (FDA) has placed a clinical hold on [LogicBio's] Investigational New Drug (IND) submission for LB-001 for the treatment of methylmalonic acidemia (MMA) pending the resolution of certain clinical and nonclinical questions." Based on this news, shares of LogicBio fell by almost 32% on February 11, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576700

IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Insperity, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insperity, Inc. ("Insperity" or "the Company") (NYSE:NSP) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Insperity released its fourth quarter and full year 2019 financial results on February 11, 2020. According to the Company's press release, "the average profit per [worksite employee] per month declined from $272 in 2018 to $259 in 2019 on a higher than expected benefits cost trend due to elevated large healthcare claim activity." The Company also announced that it "recently added a new feature" to its health plan that will limit its financial responsibility for annual claim costs that exceed $1 million. Based on this news, shares of Insperity fell by more than 19% on February 12, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576697

SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CPI Aerostructures, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CPI Aerostructures, Inc. ("CPI" or "the Company") (NYSE:CVU) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CPI announced on February 14, 2020, that its financial statements for the three and nine months ended September 30, 2018 reported in its Form 10-Q could no longer be relied upon. The Company admitted that it had discovered an "error . . . in the Company's billing process." The Company confessed that the "error" inflated revenues and income before provision for income tax, net income, and earnings per share for each period. The Company also disclosed that investors could not rely upon the independent auditor's reports on the effectiveness of internal control over financial reporting for the year ended December 31, 2018, as well as the management's reports on the effectiveness of internal control over financial reporting, press releases, and investor communications. CPI also announced the resignation of its CFO. Based on this news, shares of CPI fell by more than 26% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 576696

cbdMD Winning Product of the Year Is A Big Deal And Here’s Why

NEW YORK, NY / ACCESSWIRE / February 17, 2020 / Let's get to the point of it all: this was the first year that Product of the Year USA provided a category for CBD companies and cbdMD is the first and only CBD company to win a Product of the Year award.

"These awards are the culmination of everyone's effort, and I couldn't be more proud," said Martin Sumichrast, Chairman and co-CEO of cbdMD.

This award serves as the validity of all the efforts that cbdMD has made throughout the past years. It serves as a testament to the strength of cbdMD in providing products, programs, and services that enrich people's lives through wellness.

cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD) has continuously set the standard for quality in the wellness industry. Their products, CBD PM and CBD Freeze products have been voted the winner of the prestigious 2020 Product of the Year award in the CBD Sleep Aid and CBD Topical categories, respectively.

Being part of the list was already a pretty big deal but winning Product Of The Year for not only one product but two means cbdMD deserves major respect. They have continued to prove why they are at the top of the industry. Furthermore, it serves as a testament to the core belief of cbdMD which is quality over quantity and lifelong mission to enrich people's lives through their products.

Aside from that, this year's award had the biggest response rate. There were 40,000 voters who participated in the independent online research conducted by Kantar Media Group. This is by far America's largest consumer-voted award for product innovation. Ken Cohn, the cbdMD Chief Marketing Officer, accepted the award on behalf of the company during a special ceremony in New York City.

Their award-winning products CBD PM and CBD Freeze are two of cbdMD's most popular products in the market. CBD PM is popularly incorporated by athletes to their nighttime routine. It helps them with their anxiety, insomnia, and helps them sleep better at night. Athletes struggle with pain and aches all throughout their body after training every day but with CBD PM, they have a good night's sleep. CBD PM contains superior broad-spectrum CBD, melatonin, and a unique blend of soothing herbs.

The CBD Freeze combines the pain-relieving properties of menthol with the natural power of domestically sourced CBD. Available as a gel roller or squeeze lotion, it is the perfect solution for soothing pain, cramps, and other joint and muscle problems. The CBD Freeze Pain Relief combines the pain-relief and cooling properties of organic ingredients like menthol, aloe vera extract, and tea tree oil with high-quality CBD. This tropical salve is consistently given high ratings by athletes who use it after intense physical activity.

cbdMD continues to lead the industry with a variety of products and concentrations that they offer at affordable prices. Their current products include CBD tinctures, CBD capsules, CBD sleep aids, CBD gummies, CBD topicals, and CBD bath bombs.

For more information on cbdMD, please visit www.cbdmd.com or email pr@cbdmd.com

SOURCE: cbdMD

ReleaseID: 576690